






















































































































































































An Individual Participant Data Meta-analysis: Behavioral
Treatments for Children and Adolescents With
Attention-Deficit/Hyperactivity Disorder
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Objective: Behavioral interventions are well established treatments for children with attention-deficit/hyperactivity disorder (ADHD). However,
insight into moderators of treatment outcome is limited.
Method: We conducted an individual participant data meta-analysis [IPDMA], including data of randomized controlled behavioral intervention trials
for individuals with ADHD <18 years of age. Outcomes were symptoms of ADHD, oppositional defiant disorder (ODD), and conduct disorder (CD)
and impairment. Moderators investigated were symptoms and impairment severity, medication use, age, IQ, sex, socioeconomic status, and single
parenthood.
Results: For raters most proximal to treatment, small- to medium-sized effects of behavioral interventions were found for symptoms of ADHD, inat-
tention, hyperactivity/impulsivity (HI), ODD and CD, and impairment. Blinded outcomes were available only for small preschool subsamples and lim-
ited measures. CD symptoms and/or diagnosis moderated outcome on ADHD, HI, ODD, and CD symptoms. Single parenthood moderated ODD
outcome, and ADHD severity moderated impairment outcome. Higher baseline CD or ADHD symptoms, a CD diagnosis, and single parenthood
were related to worsening of symptoms in the untreated but not in the treated group, indicating a protective rather than an ameliorative effect of behav-
ioral interventions for these children.
Conclusion: Behavioral treatments are effective for reducing ADHD symptoms, behavioral problems, and impairment as reported by raters most prox-
imal to treatment. Those who have severe CD or ADHD symptoms, a CD diagnosis, or are single parents should be prioritized for treatment, as they
may evidence worsening of symptoms in the absence of intervention.
Key words: behavioral interventions, ADHD, individual participant data meta-analyses, moderator analyses

















197A in children and adolescents is highly prevalentand impairing in multiple domains of function-
ing.3 It is a heterogeneous disorder regarding etiology,
symptomatology, functional impairments, developmental
expression, and comorbid psychopathology; common
comorbidities are oppositional defiant disorder (ODD),
conduct disorder (CD), anxiety disorder, and depression.4Journal of the American Academy of Child & Adolescent Psychiatry
Volume& / Number& / & 2021Pharmacological and behavioral interventions are well-
established treatments for children and adolescents with
ADHD,5−7 with behavioral interventions often targeting
comorbid pathology and ADHD-related impairments.5
There is a clear need for behavioral treatments in clinic-
based practice, as they may be preferred by patients and
families8,9 and can reduce the need for medication.9−11 The

















































































































































































































404children with ADHD makes it unlikely that behavioral
treatments will work equally for all individuals, emphasizing
the need for more personalized treatment plans.
Moderation analysis allows the identification of sub-
groups of children (or families) that are more or less likely
to respond to behavioral interventions.12 To date, meta-
analyses in ADHD samples could not consistently identify
moderators of behavioral treatment response, most possibly
due to lack of power or related to the diversity of sample
compositions and study designs.13 For example, child age
was found to be a significant moderator in 1 meta-analysis9
but not in 2 others.14,15
Individual treatment studies are mostly not designed or
powered for moderation analyses.12,16 An example of 1 of
the few adequately powered studies for moderation analyses
in ADHD samples is the Multimodal Treatment Study of
ADHD (MTA),16,17 which showed comorbid anxiety of
the child to be a moderator of (better) behavioral treatment
response.9,18 The MTA study, however, was limited in age
range (79 years) and in the comparability of the behavioral
treatment arm to other behavioral treatments (ie, the MTA
behavioral treatment was far more intense than most
others). In sum, evidence regarding moderating factors is
currently inconsistent or lacking, thereby hindering clini-
cians from personalizing treatment plans.
In contrast to individual randomized controlled trials,
individual participant data meta-analysis (IPDMA) is partic-
ularly appropriate to run highly powered moderation analy-
ses, as it uses individual data from the original studies,
leading to uniform conclusions across studies.19 The
IPDMA approach has been shown to be of great advantage
in the general field of medicine; for example, an IPDMA of
Furukawa et al.20 on treatment of depression resulted in an
interactive Web tool that shows the individual predicted
disease course when taking the participants’ characteristics
into account. However, this is the first IPDMA on the treat-
ment of children and adolescents with ADHD. In the cur-
rent study, we used IPDMA to identify behavioral
intervention effects and moderators of outcomes for symp-
toms of ADHD, ODD, and CD, and global impairment in
children and adolescents with ADHD (<18 years of age).
We focused primarily on outcome measures taken from
reporters most proximal to the delivery of the treatment:
parent-rated outcomes for parent training and child-focused
treatments, and teacher-rated outcomes for interventions
that were primarily school based. Furthermore, we aimed to
explore intervention effects on probably blinded measures,
if available. We examined whether several variables that are
routinely identified in everyday clinic-based practice moder-
ated treatment effects. Identification of such moderators
could yield a more personalized approach to intervention in2 www.jaacap.orgclinical settings. We used a hypothesis-generating approach,
as the increased power of IPDMA may generate significant
moderators that have never emerged in aggregated meta-
analyses or individual studies.12,16 Candidate moderators
included clinical characteristics of the child (ie, severity of
symptoms of ADHD, ODD, CD, and internalizing prob-
lems, and impairment; comorbidity with ODD, CD, anxi-
ety disorder, and depression; and medication use) and
demographic variables (ie, child’s age, IQ, and sex; social
economic status of the family, and single parenthood).METHOD
Tag gedP his IPDMA has been registered in Prospero (https://www.
crd.york.ac.uk/prospero/display_record.php?RecordID=
69877). Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) IPDMA guidel ines
for reporting were followed, and a checklist is available in
Supplement 1, available online.
Identification and Selection of Studies
Inclusion and Exclusion Criteria. We included randomized
controlled trials (RCTs) of behavioral treatments of individ-
uals of individuals less than 18 years of age with ADHD
(corroborated by clinical cutoffs on questionnaires or
[semi]-structured interviews) and/or participants meeting
clinical cutoffs on questionnaires or (semi)-structured inter-
views. RCTs had to compare behavioral interventions with
a control condition (including active control conditions,
except for medication; see below), or studies that compared
2 behavioral interventions. For the studies with head-to-
head comparisons of 2 behavioral treatments, we coded
both active interventions as intervention, but for studies
with an active non-pharmacological control condition (eg,
weekly support groups), we coded the control condition as
an active control condition. Behavioral interventions were
defined as interventions directed at changing children/ado-
lescents’ behaviors (ie, increasing desirable behaviors and
decreasing undesirable behaviors), using (cognitive)behav-
ioral therapeutic techniques modeled to the definition used
by Daley et al.11 These include (cognitive)behavioral
interventions, such as parent- and teacher-mediated treat-
ments, as well as (cognitive)behavioral interventions
aimed directly at the child/adolescent, such as behavioral
skills training or (cognitive)behavioral therapy. We
excluded studies or intervention arms that used optimized
medication treatment next to a behavioral intervention as
part of their study design or as a control condition. English-
, German-, and Dutch-language publications published in
peer-reviewed journals were included. No date restriction
was applied.Journal of the American Academy of Child & Adolescent Psychiatry
Volume& / Number& / & 2021
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606Selection and Screening of Studies. A 2-step approach
was used to identify relevant articles. First, we searched
Medline, CINAHL, PsycINFO, EMBASE+EMBASE
CLASSIC, ERIC, Web of Science (Science Citation Index
Expanded) up to July 2017 for relevant papers using a com-
bination of the following search terms and their synonyms,
as well as hierarchical family form (eg, MeSH terms): treat-
ment specific terms (ie, behavioral treatment, psychosocial
treatment, parent and/or teacher training), ADHD, child
and adolescent, and randomized controlled trial (complete
search criteria available in Supplement 2, available online).
Two authors (APG, senior researcher, and RH, PhD stu-
dent) performed the selection and screening of studies using
Rayyan, a web and mobile app for systematic reviews21; dis-
agreement was resolved by consensus with a third person
(either ML, SvdO or BvdH, senior researchers). Second, lit-
erature lists of relevant articles (identified studies and previ-
ous systematic reviews and meta-analyses) were hand-
searched to identify possible missing articles.
Data Collection and Management
Data collection. We contacted the corresponding authors
of all selected trials by e-mail to ask to share their data, with
a reminder after several weeks. If we failed to establish con-
tact with the corresponding author, we emailed co-authors
of the study. Furthermore, we contacted authors of selected
papers during conferences and through our personal net-
work. Each author signed an understanding agreeing that
they were responsible for ethical clearance in using the data.
To assess differences in results and baseline characteristics
(age, sex, comorbidities) between the studies providing data
and the studies not providing data, APG and RH also
extracted the aggregated data from the published papers of
the studies.
Data Checks and Harmonization. First, we checked the
data of all studies as obtained, and harmonized measures.
Regarding data checks, the number of participants in each
study was compared to the number of participants in the
published paper. We also checked the data by comparing
intervention and control groups on sex, age and ADHD
severity (if available) with the published data. Authors were
contacted if any deviations from the reported data were
found, and inconsistencies were resolved.
Regarding harmonization, for each dataset continuous
measures (severity of total ADHD, inattentive, hyperactiv-
ity/impulsivity [HI], ODD, and CD symptoms; severity of
internalizing problems, and global impairment) were con-
verted into z scores, using pre-interventionscore SDs
within studies (an overview of instruments per study used
for each outcome domain can be found in Table S1,Journal of the American Academy of Child & Adolescent Psychiatry
Volume& / Number& / & 2021available online). Conversion into z scores was necessary
because of the large heterogeneity in instruments used
between studies. The analyses for ADHD, ODD, and CD
focused primarily on raters closest to the intervention: that
is, parent ratings for parent training, multimodal interven-
tions, and child-focused interventions and teacher ratings
for pure school-based interventions; for impairment parent
ratings were used or, if these were not available, a clinician
or researcher ratings. Separate exploratory analyses were per-
formed, if possible, on blinded ratings (ie, observations by a
blinded rater) of ADHD, ODD, and CD symptoms. Cod-
ing of sex (men/women), age at baseline (in years), medica-
tion use at baseline (yes/no), IQ of the child, single
parenthood (yes/no), socioeconomic status (low [<high
school], medium [high school graduate or some college edu-
cation], high [>college graduate], and diagnoses of ODD,
CD, any anxiety disorder, and depression [including major
depressive disorder and dysthymic disorder] [yes/no] were
equalized across datasets.
Risk of Bias Assessment. Risk of bias assessment of the
included studies was done independently by 2 authors (a
combination of AG/ RH/LS) using the Cochrane risk of
bias tool. Random sequence generation, allocation conceal-
ment, blinding of outcome assessment, incomplete outcome
data, vested interest, and selective outcome reporting were
rated on a 3-point scale (no risk of bias, unknown, or risk of
bias). Any disagreement was resolved by consensus.
Analyses
Analyses Between Studies Providing Data and Not Pro-
viding Data. To assess possible differences between studies
that provided data and those that did not, we examined
(available) demographic differences (percentage of male par-
ticipants, ODD and CD, and mean age), region of origin
(Europe, Northern America, other), sample size, type of
intervention (parent, teacher, child, or multimodal treat-
ment), and publication date based on data described in the
manuscript using independent t tests. Furthermore, we
examined whether there were differential intervention
effects between studies that provided data and those that
did not. For studies that provided data, we calculated ESs
based on the IPD; for studies in which IPD was not avail-
able, ESs were calculated based on aggregated data from the
manuscripts. ESs were compared using random effects
meta-analysis with the “Metafor” package in R, for the
main outcomes (ADHD, inattentive symptoms, HI, ODD,
CD, and global impairment). It should be noted that these
comparisons were possible only for those studies with a con-
trol group, and not for head-to-head comparisons (ie, com-














































































































































































































808head-to-head comparison, both interventions were coded as
intervention.
Analyses of Main and Moderator Effects. Analyses were
conducted using the “LME4” package in R (version
1.2.1335).22 We determined effects using a 1-stage
IPDMA, in which data from participants across studies
were analyzed in 1 stage, with a random intercept for
study. First, linear multilevel analysis was used to examine
effects of behavioral interventions on symptoms of total
ADHD, inattentive, HI, ODD, and CD symptoms and
global impairment. Post-measurements of total ADHD,
inattentive, HI, ODD, and CD symptoms and global
impairment were used as outcomes in these models, and
pre-intervention measures and intervention group were
added. Because all outcomes were transformed to z scores,
the regression coefficients can be interpreted as effect sizes
(ESs) (a coefficient of 1 is a change of 1 SD in the outcome
measure) and can be interpreted as small d = 0.2; medium,
d = 0.5; and large, d = 0.8.23 Heterogeneity between stud-
ies with regard to the outcome measure was assessed using
intraclass correlation (ICC). This measure varies between
0 (low clustering within studies) and 1 (high clustering
between studies) and determines the proportion of vari-
ance accounted for by clustering within studies. Of note,
this is not an appropriate indication of variance in effect
sizes between studies, as we included both studies compar-
ing 2 interventions and studies with a control group as
comparison.
Second, to test effects of the candidate moderators, we
added the interaction between intervention group and can-
didate moderator to the models, with separate models for
each outcome and moderator. BenjaminiHochberg24 cor-
rection (based on 17 tests per outcome) was used to exert
control over the false discovery rate.
Prespecified Additional Analyses. First, significant moder-
ator effects were further explored by examining 3-way inter-
actions between the moderator and possible explanatory
variables included in the IPDMA. Second, analyses were
rerun separately for parenting interventions and child/ado-
lescent-focused treatments, to assess the effect of interven-
tion type. Third, analyses were re-run on blinded measures.
Fourth, in addition to dimensionally looking at age as a
moderator, a categorical variable of age was also used to
assess differential treatment effects by comparing 3 mean-
ingful developmental stages: children <6 years; children
between 6 and 12 years; and children >12 years. Finally,
to examine whether the deterioration of ADHD symptoms
depended on the type of control condition (WL or
TAU/active control), we further tested whether there was a4 www.jaacap.orgsmaller intervention effect on the main outcome in studies
with a TAU/active control condition, compared to a WL
condition.RESULTS
Collected Data
We identified 17,897 studies; after removal of duplicates,
10,351 studies were screened based on title and abstract.
Authors AG and RH disagreed on 1.2% of decisions; these
were resolved by consensus. From 284 full-text papers that
were screened, 62 were deemed eligible. Regarding these,
we received 23 datasets. A summary of unrecovered stud-
ies (n = 37) is available in Table S2, available online. In
addition, we received data from 2 studies that were pub-
lished at a later date than our initial search25,26 (also see
Figure 1 for PRISMA flow chart). To assess whether the
addition of these 2 studies influenced the results all analy-
ses were rerun excluding these studies (see Supplement 3
[Tables S3S8], available online); results remained
approximately similar). Data checks on the provided data
led to only minor deviations that could be resolved with
the corresponding author, and mostly considered the
inclusion of more participants in the IPDMA compared to
the reported data.
With a recent systematic search (up to May 13, 2020),
using the same criteria and methods as for the current study,
we verified whether we had missed more recent studies. We
identified 8 new studies that met our inclusion criteria, of
which 2 studies25,26 were already identified when inquiring
about older studies. Data from these 2 studies were included
in the current IPDMA; the other 6 studies were not
included.
A total of 2,885 participants (1,936 intervention and
949 control) with a mean age of 8.78 years (SD = 3.32
years; range 217.5 years) were included from a total of 25
studies (Table 127−48 X Xfor a summary of studies that pro-
vided data). In almost all studies, the informant was the par-
ent, except for 1 school-based treatment for which teacher
ratings were used.31 For the current paper, 21 studies
(n = 2,233) had most proximal ratings available. Only 3
studies of parenting interventions (all in preschool children)
contained data on a probably blinded inattention measure
(directly observed time on task, n = 295),26,30,45 and only 4
studies (all in preschool children) contained data on blinded
outcome measures for disruptive behaviors (child noncom-
pliance, n = 175).34,35,45,47 Given the small sample size, spe-
cific age group, and variability in measures, analyses on the
probably blinded outcomes can be found in Supplement 4,
available online. In X X short, no effects of behavioral interven-
tions were found on these outcomes.Journal of the American Academy of Child & Adolescent Psychiatry
Volume& / Number& / & 2021
FIGURE 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Individual Participant Data (IPD) Flow
Diagram
ARTICLE IN PRESS
AN IPDMA ON BEHAVIORAL INTERVENTIONS FOR ADHD
5www.jaacap.orgJournal of the American Academy of Child & Adolescent Psychiatry









































































































































































































































Aghebati et al. 201427 27 14 Triple P 13 Parent 8.04 (1.40) 27 (100) 11 (40.7) 7 (25.9) 11 (40.7) 9 (33.3) 0 (0) Iran
Boyer et al. 201528 184 94 Plan My Life, 91
Solution-focused
treatment,
0 Multimodal 14.45 (1.26) 141 (79.2) 53 (28.6) 31 (17.0) 84 (46.2) 67 (36.8) 25 (14.4) 57 (30.8) 0 (0) 32 (20.1) 14 (8.8) Netherlands
Chronis-Tuscano et al.
201329
98 51 Standard BPT, 47
integrated parenting
intervention (IPI-A)
0 Parent 8.78 (2.06) 58 (59.2) 33 (33.7) 1 (1.1) 30 (33.0) 60 (65.9) 51 (52) 17 (17.3) USA Caucasian (48.98%), African
American (30.61), Other
(20.41)
Daley et al. 2013 30 43 19 New Forest Parenting
Programme
24 Parent 7.28 (1.53) 0 (0) 8 (18.6) UK
Dupaul et al. 200631 176 0 Teacher 8.58 (1.19) 51 (29) 43 (24.4) 18 (8.6) 136 (64.8) 56 (26.7) 0 (0) 0 (0) USA White (58.23)
Franke et al. 201632 53 27 Triple P 26 Parent 3.97 (0.59) 38 (71.7) 10 (18.9) 14 (26.4) 29 (54.7) New Zealand New Zealand European
ethnicity (79.2%)
Gershy et al. 2017 33 57 23 Nonviolent resistance
(NVR)
34 Parent 9.56 (2.49) 14 (17.7) 42 (28.0) 82 (54.7) 26 (17.3) Israel
Herbert et al. 201334 31 17 Parenting Your
Hyperactive Preschooler










52 Multimodal 11.98 (1.03) 149 (53.2) 75 (26.8) 117 (45.9) 89 (34.9) 49 (19.2) 127 (45.4%) 85 (30.4) 10 (3.6) 12 (4.3) 73 (26.1) USA White (54.74%),
Black (28.46%).
Asian (1.46%),
American Indian (1.1 %),
Multiracial (0.58%)
Mautone et al. 201235 61 29 Family school success
early elementary






Mikami et al. 201036 62 32 Parent friendship
coaching




More than 1 race (7%)





0 Teacher 9 (56.3) 11 (45.8) 0 (0) 12 (50) USA White (81%),
Asian American (6%),
Latino (2%),
More than 1 ethnicity (8%)
MTA group 199917 a 287 143 Parent training summer
treatment program
144 Multimodal 7.76 (0.82) 57 (19.9) 121 (45.3) 41(14.3) 14(4.9) 96 (33.4) USA White (61%),
African American (20%),
Hispanic (8%),
Pfiffner et al. 200738 69 36 Child life and attention
skills program



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































73 Multimodal 13.99 (1.43) 56 (49.6) 16 (14.2) Germany
Sibley et al. 201343 36 18 Supporting Teens’
Academic
Needs Daily
18 Multimodal 12.39 (1.02) 20 (55.6) 10 (27.8) 2 (5.6) 12 (33.3) 22 (61.1) 7 (19.4) 10 (27.8) 5 (15.6) 21 (63.6) USA White non-Hispanic (25%),
Black non-Hispanic (8.35%),
Hispanic, any race (61.15%),
Mixed race (5.55%)
Sibley et al. 201644 128 67 Supporting Teens’
Academic
Needs Daily






306 133 New Forest Parenting
Programme,
131 Incredible Years
42 Parent 3.51 (0.58) 0(0) 82 (26.8) 92 (33) UK
Thompson et al.
200945
41 21 New Forest Parenting
Programme
20 Parent 4.18 (1.05) 0 (0) 50 (100.0) 32 (76.2) 7 (16.7) 3 (7.1) UK
Van Den Hoofdakker
et al. 200746
94 47 Behavioral parent
training




Webster-Stratton47 99 49 Incredible years,
combined parent and
child
50 Multimodal 5.36 (0.91) 0 (0) 24 (24.2) 20 (20.8) USA Minority (27.3%)
Xie et al. 201348 22 13 Parent Training face to
face,
9 Parent training video-
conferencing
0 Parent 8.95 (1.89) 7 (31.8) USA
Note: CD= conduct disorder; n = number of participants; ODD= oppositional defiant disorder; SES = socioeconomic status.
aSome data were not available in the public access database of the Multimodal Treatment Study of ADHD (MTA) (ie, medication at baseline and single parenthood).











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Risk of bias agreement was high (k = 0.92) and is presented
in Figure 2 (separate panels for those studies providing data
and those not; see Figure S1 and Figure S2, available
online). Results (based on manuscripts) showed that for
many studies it was unclear how random sequences were
generated (56%) and how allocation concealment took
place (68%). In almost all studies, selective reporting was
unclear (84%), as few studies preregistered their trials. A
visual comparison between studies participating and those
not participating showed that in the studies not participat-
ing, there were slightly more problems in allocation conceal-
ment, and more potential vested interests. Overall, 28% ofFIGURE 2 Moderating Effects on Behavioral Treatment for Attent
Note: (A, B) Moderating effect of CD diagnosis on ADHD symptoms post-intervention.
vention. (D) Moderating effects of CD symptoms at baseline on hyperactive impulsive o
ODD outcome post-intervention. (F) Moderating effects of CD symptoms at baseline on
erating effects of ADHD symptoms at baseline on impairment post-intervention. The da
where baseline severity is similar to post-intervention severity (ie, x = y). A regression line
cates improvement at post-measurement compared to baseline, and a regression line
Number of individuals with CD with ADHD outcomes: n = 96. ADHD= attention-de
imp = impairment; ODD= oppositional defiant disorder; symp = symptoms.
8 www.jaacap.org
1541studies had risk-of-bias violations (high risk of bias) on 2 or
more items. Risk of bias (as measured by percentage of “no
bias”) was not associated with any of the results on the out-
come measures (ADHD p = .23, inattention p = .17, HI
p = .31, ODD p = .92, CD p = .17, impairment p = .75).
Analyses Between Studies Providing Data and Not
Providing Data
Studies not providing data did not differ in age
(mean = 8.48 versus mean = 8.87, p = .70), percentage of
ODD (mean = 50.60% versus mean = 40.14%, p = .29), or
CD (mean = 7.04% versus mean = 19.89%, p = .12), region
of origin p = .53), type of intervention (p = .42), but studiesion-Deficit/Hyperactivity Disorder
(C) Moderating effects of CD symptoms at baseline on ADHD outcome post-inter-
utcome post-intervention. (E) Moderating effects of CD symptoms at baseline on
CD outcome post-intervention. (G, H) Moderating effect of single parents. (I) Mod-
shed black line was added for illustrative purposes; it represents the regression line
of the intervention and/or control group below the dashed black line at x = 0 indi-
above the dashed black line at x = 0 indicates deterioration at post-measurement.
ficit/hyperactivity disorder; CD = conduct disorder; HI = hyperactivity/impulsivity,
Journal of the American Academy of Child & Adolescent Psychiatry













































































TABLE 2 Main Effects of Behavioral Interventions
n k Estimate SE df t p
ADHD 2109 20 −0.42 0.05 716.90 −9.17 <.001
Parent interventions 1689 17 −0.42 0.05 782.38 −8.8 <.001
Child focused 423 3 −0.67 0.12 287.26 −5.68 <.001
Inattention 2,173 20 −0.46 0.05 662.48 −9.52 <.001
Parent interventions 1,635 16 −0.45 0.05 758.61 −8.61 <.001
Child focused 541 4 −0.64 0.10 290.02 −6.17 <.001
HI 2,233 21 −0.27 0.04 2230.00 −7.43 <.001
Parent interventions 1,692 17 −0.31 0.04 1689 −7.40 <.001
Child focused 544 4 −0.35 0.08 138.94 −4.52 <.001
ODD 1,798 16 −0.19 0.04 1413.62 −4.83 <.001
Parent interventions 1,568 14 −0.20 0.04 1460.05 −4.93 <.001
Child focused a
CD 1,229 12 −0.20 0.06 1226.00 −3.38 <.001
Parent interventions 882 9 −0.23 0.05 879.00 −4.92 <.001
Child focused a
Impairment 664 8 −0.59 0.10 661 −5.96 <.001
Parent interventions 567 7 −0.68 0.11 564.00 −6.19 <.001
Child focused a
Note: Boldface typeQ4 X Xindicates models that remained significant after multiple testing correction. Full analyses on parent- and child-focused treatments
are provided in Supplements 6 and 7 (Tables S15−S26), available online. ADHD= attention-deficit/hyperactivity disorder; CD = conduct disorder;
df = degrees of freedom; HI = hyperactivity/impulsivity; k = number of studies; n = number of individuals; ODD= oppositional defiant disorder;
SE = standard error.
aThere were not enough observations to run these analyses.
ARTICLE IN PRESS










































































































































































































1818not providing data did have a slightly larger percentage of
male participants (mean = 79.64% versus mean = 70.93%,
p = .007), smaller samples sizes (mean = 64 versus
mean = 113, p = .017), and an earlier publication date
(mean = 2008 versus mean = 2012, p = .044). No differen-
ces in ESs were found for the intervention effects on
ADHD symptoms (difference in ESs [estimate] = 0.18,
p = .39), inattentive symptoms (estimate =0.04, p = .80),
hyperactive/impulsive symptoms (estimate = 0.11, p = .48)
or CD (estimate =0.03, p = .89). However, studies that
provided data appeared to have a smaller effect on ODD
symptoms (estimate = 0.29, p = .03) compared to studies
that did not provide data.
ADHD Symptoms
Behavioral interventions had a positive, small to medium ES
on ADHD symptoms (b =0.42, p < .001) (Table 2, and
Supplement 5 [Tables S9S14], available online). The pro-
portion of variance accounted for by clustering within stud-
ies was low (ICC = 0.05). This effect remained significant
in parenting interventions (b =0.42, p < .001) and in
child/adolescent focused interventions (b =0.67, p <
.001) (Table 2, and Supplements 6 and 7 [Tables
S15S26], available online). Symptoms of CD (b = 0.19,
p = .002) and a diagnosis of CD at baseline (b = 0.55, p =
Journal of the American Academy of Child & Adolescent Psychiatry
Volume& / Number& / & 2021.008) moderated the intervention effect. Figures 2 and 3
show that this effect was driven by an increase in ADHD
symptoms in the control group for children with more base-
line symptoms of CD Figure 2C, and/or a baseline diagnosis
of CD Figure 2A and B, compared to youths with fewer CD
symptoms and/or no CD diagnosis, or youths in the inter-
vention group. No other investigated candidate factor mod-
erated the intervention effect on ADHD symptom severity
(Table 3).
Additional analyses (see Supplement 8, available online)
showed that the moderating effect of CD symptom severity
and/or CD diagnosis did not vary as a function of any of
the other variables, and remained significant in parenting
interventions only (b = 0.22, p = .002; b = 0.55, p =
.008, respectively).Inattention Symptoms
Behavioral interventions had a positive, small- to medium-
sized effect on inattention symptom severity (b = 0.46, p
< .001), with low clustering within studies (ICC = 0.07).
This effect remained significant in parenting interventions
only (b =0.45, p < .001) and child-focused interventions
(b =.64, p < .001) (Table 2). None of the investigated
variables moderated the intervention effect (see Table) X X.9www.jaacap.org
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TABLE 3 Moderating Effects of Child/Adolescent and Family Factors on Outcomes of Behavioral Interventions for Attention-
Deficit/Hyperactivity Disorder (ADHD)
ADHD Inattention HI ODD CD Impairment
N k ES n k ES n k ES n k ES n k ES n k ES
ADHD symptoms 2,109 20 −0.09 2035 18 −0.01 2112 20 −0.03 1786 16 −0.01 1104 11 −0.12 659 8 0.50
Age 2,109 20 0.10 2173 20 −0.03 2233 21 0.03 1798 16 −0.01 1229 12 0.01 664 8 −0.03
CD symptoms 1,309 12 −0.19 1405 12 −0.09 1435 13 −0.14 1092 10 −0.21 1229 12 −0.21 563 6 −0.17
Diagnosis anxiety 1,199 9 −0.05 1208 9 −0.25 1208 9 −0.15 1001 8 −0.13 647 5 −0.07 361 4 0.90
Diagnosis CD 1,515 12 −0.55 1528 12 0.20 1529 12 −0.37 1320 11 −0.36 1063 9 −0.44 604 6 −0.90
Diagnosis depression 1,105 8 0.01 1114 8 −0.47 1114 8 −0.46 907 7 −0.15 648 5 −0.19 360 4 −2.06
Diagnosis ODD 1,624 14 0.11 1636 14 0.09 1637 14 0.01 1428 13 −0.09 1051 9 −0.22 606 6 −0.31
Impairment 687 8 −0.17 692 8 −0.01 691 8 −0.05 519 6 −0.09 465 4 −0.16 664 8 0.1
Internalizing symptoms 1,203 11 −0.09 1227 12 −0.07 1215 11 −0.08 1010 10 −0.11 620 6 −0.16 588 6 −0.25
IQ 949 8 0.19 953 8 0.01 951 8 0.00 942 8 0.00 589 5 0.00 387 4 0.00
Medication use at baseline 1,738 16 −0.01 1827 16 0.05 1861 17 0.16 1466 13 −0.07 955 10 −0.16 645 7 −0.03
ODD symptoms 1,981 17 −0.06 1987 17 −0.06 1989 17 −0.03 1798 16 −0.08 1079 10 −0.05 615 7 −0.24
SES high vs low 1,386 15 −0.02 1342 14 −0.01 1399 15 0.03 1134 12 0.28 817 9 0.56 595 6 0.10
Sex 2,109 20 −0.55 2173 20 −0.42 2233 21 0.09 1798 16 0.01 1229 12 0.17 664 8 0.42
Single parent (yes) 1,306 10 −0.20 1309 10 −0.27 1314 10 −0.12 1195 9 −0.29 568 4 −0.13 539 5 0.11
Note: Boldface type indicates significant findings multiple testing correction. All linear multilevel analysis models have post-measurement score as
outcome and are corrected for baseline impairment score. Every moderator was tested in an individual model. Full information on all models can be
found in Supplement 5 (Tables S9−S14); correlation matrix between all moderators can be found in Table S27, available online. ADHD= attention-def-
icit/hyperactivity disorder, CD = conduct disorder; df = degrees of freedom; k = number of studies; n = number of individuals; ODD= oppositional













































































































































































































Behavioral interventions had a positive, small effect on HI
symptom severity (b = 0.27, p < .001), with low clustering
within studies (ICC = 0.01) (Table 3). This effect remained
significant in parenting interventions (b =0.31, p<.001)
and child/adolescent focused interventions (b =0.35, p <
.001) (Table 2). CD symptoms moderated intervention effect
(b = 0.14, p = .002); Figure 2D shows that youths with
higher CD symptom severity in the control group increased
more in HI symptom severity compared to youths with fewer
CD symptoms, or youths in the intervention group.
Additional analyses (see Figure S3, available online),
showed a significant 3-way interaction among age, CD
severity, and intervention condition (p = .004); a median
split (age 8.6 years) showed that younger children with
higher CD symptom severity in the control group had a
worse outcome compared to younger children in the inter-
vention group on HI symptom severity, but this effect was
not significant in older children. The effect of CD symptom
severity remained significant in parenting interventions only
(b = 0.20, p < .001), but not in studies on child/adoles-
cent-focused interventions (b = 0.00, p = .99).
ODD Symptoms
Behavioral interventions had a significant positive, small ES
on symptoms of ODD (b = 0.19, p < .001), with low
10 www.jaacap.orgclustering within studies (ICC = 0.02) (Table 3). This effect
remained significant in parenting interventions (b =0.20,
p < .001); the number of studies was too low for analysis in
child/adolescent-focused studies. Youths with more baseline
CD symptoms (b = 0.21, p < .001; also see Figure 2E)
and youths with single parents (Figure 2G and H) (b =
0.29, p = .006) showed a larger intervention effect. Fig-
ures 3 shows that both moderating effects were driven by a
deterioration of those with high CD symptoms or single
parents in the control group.
Additional analyses (see Supplement 8, available
online), showed that the moderating effect of CD symptom
severity and/or single parenthood did not vary as a function
of any of the other variables. The moderating effect of base-
line CD severity and single parenthood remained significant
in studies on parenting interventions only (b = 0.21, p <
.001; b = 0.31, p = .004 respectively).
CD Symptoms
Behavioral interventions had a positive, small ES on CD
symptom severity (b = 0.20, p < .001). The proportion of
variance accounted for by clustering within studies was low
(ICC < 0.001) (Table) X X. This effect remained significant in
parenting interventions (b =0.23, p < .001) (Table 2);
the number of studies was too low for analysis in child-
focused studies. Youths with higher baseline CD symptomJournal of the American Academy of Child & Adolescent Psychiatry
Volume& / Number& / & 2021
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2148severity showed a larger intervention effect (b = 0.21, p <
.001), although this seems to be driven by a larger deteriora-
tion of those with high CD symptoms in the control group
(Figure 2F).
Additional analyses showed a significant 3-way inter-
action among baseline ADHD severity, baseline CD
severity, and intervention condition (p = .02); those with
high ADHD and high CD symptom severity, but not
those with low ADHD symptoms and high CD symp-
toms, showed worse outcome post-intervention in the
control group (see Figure S3, available online) The effect
of baseline CD symptom severity remained significant











































Behavioral interventions had a positive, medium-sized
effect on global impairment (b = 0.59, p < .001). The
proportion of variance accounted for by clustering within
studies was low (ICC < 0.001) (Table 3). This effect
remained significant in parenting interventions
(b =0.68, p < .001); the number of studies was too low
for analysis in child-focused studies. Individuals with
higher baseline ADHD symptom severity showed smaller
intervention effects (b = 0.50, p < .001) than those with
low baseline ADHD symptoms, although this effect seems
to be driven by a larger deterioration in impairment in the
control group (Figure 2I). Additional analyses (see Sup-
plement 8, available online), showed that the moderating
effect of ADHD symptom severity did not vary as a func-
tion of any of the other variables (including control condi-
tion). The effect of baseline CD symptom severity
remained significant in studies on parenting interventions
































2222Additional Analysis Regarding Age and Control
Condition
Age as a dimensional variable did not moderate intervention
outcome on any of the outcome variables (see Supplement
8, available online).
When compared to TAU/active controls, the effect
of behavioral intervention on the outcome variables we
found that the intervention effect was smaller compared
to those in a WL condition on symptoms of ADHD X X
(b = 0.47, p < .001), inattention (b = 0.66, p < .001),
HI (b = 0.25, p = .002), ODD (b = 0.28, p < .001),
and CD (b = 0.35, p < .001), but not impairment
(b = 0.06, p = .79). Of the previously identified modera-
tors, the control condition affected only the relation
between CD symptoms on CD symptoms; individualsJournal of the American Academy of Child & Adolescent Psychiatry
Volume& / Number& / & 2021in the WL condition performed worse than those in a
TAU/active control group (b = 0.27, p = .009).DISCUSSION
The present study is the first IPDMA on behavioral inter-
ventions for children and adolescents with ADHD. Its large
database, including data from 21 randomized controlled
studies and behavioral treatment outcomes of 2,233 chil-
dren and adolescents with ADHD, enabled moderator anal-
yses of sufficient statistical power. Results showed robust
evidence that behavioral interventions reduced ADHD
symptoms, behavioral problems, and global impairment
according to reports of raters most proximal to the delivery
of the intervention, with small- to medium-sized effects.
The intervention effect size in this IPDMA was highest for
impairment, which, for most interventions, is the primary
treatment target.5,27 Moreover, on total ADHD symptom
severity reduction, we found a seemingly larger effect size
compared to those of aggregated data meta-analyses (eg,
Boyer et al.28). Our analyses clearly showed the added value
of IPDMA compared to other designs, as we uncovered
moderators that could not be identified in earlier meta-anal-
yses or randomized controlled trials. CD (baseline symp-
toms as well as comorbid diagnosis) moderated treatment
effects. For all outcome measures except inattention and
global impairment, higher baseline CD symptomatology
(and/or a diagnosis of CD) was associated with larger treat-
ment effects. For HI symptoms, this moderating effect was
found only in younger individuals (<8.6 years of age, using
a medium split) X X. For CD, the moderating effect was present
only in those with more severe (z scores >0) baseline
ADHD symptom severity.
The larger benefit of behavioral interventions in chil-
dren with more severe CD may seem consistent with some
of the existing literature on intervention effects for children
with conduct problems; however, most studies did not
report whether effects were driven by the intervention or
control condition.29 Our results clearly show that positive
intervention effects in children with elevated CD symptoms
were driven by larger symptom deterioration in the control
condition (mostly TAU or WL). These findings suggest
that youths with more severe CD symptoms are more likely
to suffer an increase in symptoms of ADHD and behavioral
problems over time, particularly when not treated, empha-
sizing the importance of direct access to care. A similar mod-
erating effect was found for ADHD symptoms on global
impairment. In addition, this group did not improve (and
even seems to deteriorate for HI and CD outcomes) from
pre- to post-assessment in the active treatment condition,













































































































































































































2424behavioral interventions for those with more severe CD
symptoms or ADHD symptoms. Perhaps treatments for
this subgroup of children with severe behavioral problems
should be more intensive than routine ADHD interventions
and enhanced with CD-specific components.32
With respect to the moderation effect of single parent-
hood, a similar pattern emerged. The data suggest that
youth from single-parent families deteriorated with regard
to ODD symptoms in the control condition, indicating
that children and adolescents from single-parent families
should also be treated immediately. Moreover, this particu-
lar subgroup did not improve substantially in terms of
ODD symptoms in the behavioral treatment condition,
again indicating a protective rather than an ameliorative
effect of behavioral interventions. Treatments that are tai-
lored to the specific needs of single-parent families may
therefore be more suitable for this subgroup. For example, a
study by Chacko et al.37 in X X families of children with
ADHD showed that children’s ODD symptoms reduced
significantly only after a behavioral parent training program
that was specifically designed for single mothers, whereas
this effect was not present in children whose mothers
received standard parent training.
Other potential moderators were not significant, sug-
gesting equal effectiveness of behavioral interventions across
children’s age, IQ, sex, medication status, and child’s
comorbidity with ODD, anxiety, and depression, as well as
socioeconomic status and impairment severity. For age,
additional analyses showed no differential effect of behav-
ioral interventions on any of the outcome measures in indi-
viduals less than 6 years of age, between 6 and 12 years, and
more than 12 years. The lack of a moderating effect of age
or socioeconomic status is in line with the only currently
available IPDMA on effects of 1 specific parenting program
for behavioral problems (no specific ADHD sample) in
young children (<12 years),36 suggesting equal effectiveness
of behavioral treatments in ADHD across age groups and
socioeconomic status.
In addition, we found evidence for a specific waitlist
effect,39 as we found that children in the waitlist control
group performed worse on almost all outcomes than those in
the TAU/active control condition.39,40 Given the negative
effects of waiting for behavioral intervention, efforts should
be made to make behavioral interventions easily and quickly
accessible to all, for example, by integrating them into regular
services and daily lives of parents and children (eg, in schools,
primary care practice, or community services) and to reduce
waitlists to a minimum, especially for those with severe
behavioral problems. Telehealth and digital approaches may
also be of value in increasing access and uptake of behavioral
interventions,40,41 and moreover could be cost-effective.12 www.jaacap.orgMajor strengths of our IPDMA are that we rigorously
analyzed a large database, thereby covering a range of out-
comes and potential moderators. Although we included just
over one-third of eligible studies, our database was represen-
tative of all eligible behavioral intervention studies, given
the similar ESs reported in included and not included stud-
ies. Moreover, as in IPDMA the number of participants is
of importance, our IPDMA did include over one-half of the
total number of participants of the eligible studies. Most of
the missing studies were older studies for which the data
were no longer available.
Limitations of our IPDMA include, first, in line with
other meta-analyses11,28 that we examined, a heterogeneous
group of behavioral interventions (eg, parent training, class-
room interventions, or skills training) that targeted different
outcomes, whereas intervention effects and moderators of
outcome may differ between intervention types.5 Future
meta-analyses, preferably using IPD, should focus on differ-
ent intervention types. Nevertheless, robust effects of behav-
ioral interventions on ADHD, behavioral problems, and
impairment were obtained, and effects remained significant
in parenting interventions only as well as child/adolescent-
focused interventions only. Second, as cannot be avoided in
an IPDMA, several assumptions had to be made in the pro-
cess of data harmonization, for example, that different meas-
ures from different trials actually measured the same
construct. However, we did find low clustering of outcomes
within studies (ICCs < 0.07), which is indicative of low
heterogeneity of constructs across studies. A third limitation
concerns the blinded measures. The number of studies
using objective measures of symptom change or impairment
that met inclusion criteria was very limited. We only
included 4 parent training studies that used objective obser-
vational measures. In addition, the measures used were
diverse (from structured play observations to audio-tapes of
problem situations), and not all were well validated, reflect-
ing the absence of appropriate objective measures for behav-
ioral interventions, which should be developed in future
studies. These should not only include behavioral measures
but impairment measures as well. Previous meta-analyses
have shown that effects of behavioral interventions on
ADHD symptoms assessed by blinded raters were not sig-
nificant.28 Thus, it remains unclear whether intervention
effects reflect actual changes in ADHD symptoms or are
limited to the perceptions of parents or teachers. However,
such changes in perceptions may, of course, be important
psychological indicators of the rater’s beliefs about child
behavior (even if not accompanied by actual changes in core
symptoms). It could also be argued that intervention recipi-
ents themselves (parents or teachers in the instance of chil-
dren) are the best raters of the child’s problems.42Journal of the American Academy of Child & Adolescent Psychiatry
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2626Furthermore, parent- and teacher-reported outcomes are
better translatable to clinic-based practices, as they are
nearly always the only available information source in clini-
cal care. Another limitation is that we included only peer-
reviewed published work, which may have been biased by a
possible exaggerated estimate of intervention effect,43
although moderator analyses on individual data may be less
influenced by this bias. Moreover, we did not have permis-
sion, which is required under the European General Data
Protection Regulation (GDPR), to include ethnicity in our
moderator analyses. Also, many studies (in fact, all of the
European studies except for 1 older study) did not collect
data on ethnicity. The majority of the American studies
reported on ethnicity; it appeared that most of the included
populations were a reasonable representation of the United
States. Finally, the systematic search of the current IPDMA
was 3 years old. Preparing and gathering the data for
IPDMA takes time (in the instance of this study, more than
2 years). However, with a recent systematic search, using
the same criteria and methods as the current study, we iden-
tified 6 datasets that were not included in the current analy-
ses. Unfortunately, as collection, preparation, and
harmonizing of those data would have taken substantial
time, we could not include these in the current study.
Future IPDMA studies should focus on parenting measures,
long-term outcomes, mediators of treatment effects (eg,
increase in parenting skills), and moderators of behavioral
treatments in relation to other treatments for ADHD, such
as medication. Future studies also need to address how to
sequence and combine behavioral and cognitive treatment
to medication and other interventions, to reduce
impairment and improve functioning of children and ado-
lescents with ADHD.44
This IPDMA showed that behavioral interventions for
ADHD are effective treatments, significantly reducing core
ADHD symptoms, associated behavioral problems, and
global impairment, as perceived by parents or teachers post-
treatment. Improvement in impairment is notable, as
impairment in functioning is generally what prompts treat-
ment seeking and is arguably the most salient outcome in
behavioral treatment. We found significant moderators of
outcome that can be translated to a clear clinical message,
although these moderators seemed to have the strongest
impact on the control condition rather than the active treat-
ment condition; in particular, children with high levels of
CD symptoms or diagnosis, children with single parents,
and children with high levels of ADHD symptoms, should
be prioritized for behavioral treatment. For these children,
treatment seems to prevent them from further deterioration
in terms of ADHD symptoms, behavioral problems, and/or
impairment.Journal of the American Academy of Child & Adolescent Psychiatry
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